HydroWhirl S tank cleaning nozzle now ATEX certified

Published: 28-Feb-2012
Manufacturing Cleaning Pharmaceutical Active Nutrition Food

For use in atmospheres that are potentially explosive

The HydroWhirl S tank washing nozzle range from BETE has recently been expanded to include ATEX certified versions for use in atmospheres that are potentially explosive.

The HydroWhirl is designed to meet the exacting standards for effective cleaning-in-place (CIP) required in the pharmaceutical, chemical, food, dairy and beverage industries. As well as being certified for use in potentially explosive areas, the ATEX certified nozzles also meet the requirements for gas and dust approvals for all zones (0,1 and 2).

HydroWhirl nozzles are self-cleaning and self-lubricating, which eliminates the possibility of process contamination, while its compact design allows it to be fitted through small, restricted access flanges. They are ideal for medium tanks (up to 5 metres in diameter), used in the pharmaceutical and chemical, food and petrochemical industries, where superior cleaning combined with reduced cycle times, lower water, energy and chemical consumption are increasingly becoming important considerations.

See more

You may also like

Manufacturing

Faster tank cleaning with PTFE nozzle

Read more
HydroWhirl Poseidon removes scum rings and tougher residues

Trending Articles

  1. You need to be a subscriber to read this article.
    Click here to find out more.
    Moving with speed and scale: innovative, material-sparing approaches to accelerate clinical development As early-stage drug development is often hindered by limited API supply, rising costs and tight timelines, material-sparing technologies are helping companies to progress faster with less
  2. Why weight sorting should move earlier in OSD development Phillip Ruda explains how earlier weight intelligence can improve process understanding, reduce risk and accelerate learning cycles
  3. Lyocontract invests €50m in new freeze-drying facility with Syntegon vial line German CDMO Lyocontract has begun construction of a €50m expansion in Ilsenburg, partnering with Syntegon to install a complete vial filling and lyophilisation line for sterile freeze-dried pharmaceuticals
  4. You need to be a subscriber to read this article.
    Click here to find out more.
    The evolution of the CDMO model in Central Europe: strategic partnerships as a catalyst for change As the Central European outsourcing market matures, companies such as Mabion are redefining the CDMO paradigm with integrated biologics expertise and long-term codevelopment partnerships that elevate the region from cost-efficient manufacturer to strategic biopharma collaborator

Upcoming event

DCAT Week

23–26 March 2026 | Conference | New York, US See all

You may also like

Manufacturing

Faster tank cleaning with PTFE nozzle

HydroWhirl Poseidon removes scum rings and tougher residues
Cleaning

Bete introduces high impact rotary tank cleaner

HydroWhirl Orbiter meets exacting cleaning standards
Ingredients

dsm-firmenich launches ModulaSENSE Bitter to tackle bitterness in oral drug formulations

The new taste modulation technology combines bitter blockers, maskers and sweeteners with receptor-based analysis to help pharmaceutical formulators improve the palatability of oral medicines
Manufacturing

Clariant opens first US pharmaceutical-grade PEG excipient manufacturing site in Texas

Clariant has expanded its Clear Lake facility in Texas to produce GMP-compliant pharmaceutical-grade polyethylene glycol excipients, marking its first US-based manufacturing site for the products and strengthening supply chain resilience for North American and Latin American pharma customers
Design & Build

ESTEVE CDMO expands spray drying and high-potency containment capacity at Girona facility

ESTEVE CDMO has announced plans to add a 3000-square-metre production unit at its Celrà site in Spain to house additional spray drying equipment and high-potency containment suites, with the first new GEA spray dryer due online in Q1 2027
You need to be a subscriber to read this article.
Click here to find out more.
Analysis

Semaglutide patent cliff: pharma industry braces for impact

With the weight-loss industry shifting from a monopoly held by innovators to a high-volume, competitive generic market, the pharma manufacturing sector is gearing up for a "generic wave" with investments into large-scale protein synthesis and facilities for injectables
Manufacturing

Abzena named a leader in Frost & Sullivan ADC CDMO radar report

Recognition highlights integrated capabilities, proprietary technology and expertise in antibody-drug conjugates
Subscribe now